Skip to main content

Table 1 Patient characteristics

From: A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use

  Total population Quality of life population Photographed population
  N=230 N=197 N=177
Age (years) 47.42 (8.40) 47.85 (8.47) 48.09 (8.78)
Sex (Male) 87.0% 86.8% 87.6%
Body Mass Index 21.59 (2.56) 21.62 (2.50) 21.63 (2.45)
Duration of HIV seropositivity (years) 16.00 (4.37) 16.10 (4.29) 16.11 (4.35)
CD4 count (CD4/mm3) 543 (299) 547 (288) 551 (306)
Viral load (< 400 copies/ml) 84.9% 84.7% 84.0%
Time since antiretroviral therapy initiated (years) 11.55 (4.02) 11.69 (3.90) 11.74 (3.98)
  1. Note: Means are provided for continuous variables with standard error of measurement (SEM) in parentheses.